Suppr超能文献

华法林与双氯西林之间的潜在相互作用。

Potential interaction between warfarin and dicloxacillin.

作者信息

Mailloux A T, Gidal B E, Sorkness C A

机构信息

School of Pharmacy, University of Wisconsin, Madison 53706, USA.

出版信息

Ann Pharmacother. 1996 Dec;30(12):1402-7. doi: 10.1177/106002809603001208.

Abstract

OBJECTIVE

To report a case and retrospective review of seven patients who experienced a decrease in prothrombin time during concomitant administration of warfarin and dicloxacillin.

CASE SUMMARY

A 41-year-old man receiving warfarin 22 mg/wk with a final baseline prothrombin time (PT) of 20.7 sec was prescribed dicloxacillin 500 mg qid for 10 days. Plasma collected for PT determinations was also used to measure trough warfarin R- and S- enantiomer concentrations. The PT and S- and R-warfarin concentrations decreased 17%, 25%, and 20%, respectively, on day 5 after initiation of dicloxacillin. For the retrospective review, the mean PT decreased 17.0% (range 10.5-25.9%) as soon as 4 days after the initiation of dicloxacillin.

DISCUSSION

Our observations, which are consistent with those of two previously published reports, suggest a close temporal relationship between the administration of dicloxacillin and a decreased anticoagulant effect of warfarin. Limited data from our patient further suggest that this may result from declines in systemic warfarin concentrations. The time course of the fall of PTs appears to occur within 4-5 days; return of the PT to baseline after dicloxacillin administration is stopped appears to take up to 3 weeks. Until further controlled studies are conducted to confirm this interaction, clinicians should be aware that patients may be at risk for a decreased anticoagulant effect of warfarin when dicloxacillin is given concomitantly.

CONCLUSIONS

Careful monitoring of international normalized ratios and titration of the warfarin dosage is recommended on initiation and for 3 weeks after discontinuation of dicloxacillin in patients receiving warfarin.

摘要

目的

报告1例病例并回顾性分析7例在华法林与双氯西林联用期间凝血酶原时间降低的患者。

病例摘要

一名41岁男性,每周服用22mg华法林,最终基线凝血酶原时间(PT)为20.7秒,被处方每日4次、每次500mg双氯西林,共服用10天。用于PT测定所采集的血浆也被用于测定华法林R型和S型对映体的谷浓度。在开始使用双氯西林后的第5天,PT以及S型和R型华法林浓度分别下降了17%、25%和20%。在回顾性分析中,在开始使用双氯西林后4天,平均PT就下降了17.0%(范围为10.5 - 25.9%)。

讨论

我们的观察结果与之前发表的两篇报告一致,表明双氯西林的使用与华法林抗凝作用降低之间存在密切的时间关系。来自我们患者的有限数据进一步表明,这可能是由于全身华法林浓度下降所致。PT下降的时间过程似乎发生在4 - 5天内;停用双氯西林后PT恢复至基线似乎需要长达3周的时间。在进行进一步的对照研究以证实这种相互作用之前,临床医生应意识到,当同时给予双氯西林时,患者可能有华法林抗凝作用降低的风险。

结论

对于正在接受华法林治疗的患者,建议在开始使用双氯西林时以及停用双氯西林后3周内仔细监测国际标准化比值并调整华法林剂量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验